Session Room 1/ Track 1 Thursday, May 5, 12:45 – 13:45	Advancing Evidence for Tacrolimus Once Daily on Liver Transplant patients
12:45-12:50	Welcome and introduction – Professor Şükrü Emre (General Surgery) Ege University Medical Faculty, Turkey
12:50-13:10	High intra-patient variability: Differential Effect of Tacrolimus – professor Dong Jin Joo, (General Surgery) Severance Hospital, Korea
13:10-13:30	Long-term clinical outcomes in liver transplant patients – when to start? – Mikel Gastaca (Hepatobiliary Surgery) Cruces University Hospital, University of the Basque Country, Spain
13:30-13:40	Live Q&A All
13:40-13:45	Closing remarks – Professor Şükrü Emre, Ege University Medical Faculty Turkey

 

 

Session Room 2/ Track 2 Thursday, May 5, 15:30 – 16:15	Management of patients after HBV-related liver transplantation
15:30 – 15:35	Welcome and Introduction – Peter Schemmer, FACS, MD, Prof, PhD, Medical University of Graz, Graz, Austria
15:35 – 15:43	The role of HBV and HBsAg in liver transplantation – Peter Schemmer, FACS, MD, Prof, PhD, Medical University of Graz, Graz, Austria
15:43 – 15:56	How can we achieve best patient outcomes after HBV-related liver Tx – Ramazan Idilman MD, Prof, Ankara University School of Medicine, Ankara, Turkey
15:56 – 16:09	The role of HBIG in modern therapy approaches – Patrizia Burra, MD, Prof, PhD, Padova University Hospital, Padova, Italy
16:09 – 16:15	Discussion

 

 

Session Room 3/ Track 3 Thursday, May 5, 15:30 – 16:15	Current practice and future aspects of viability assessment during organ perfusion
15:30-15:35	Welcome – Andrea Schlegel
15:35-15:55	My clinical practice of viability testing during HOPE – Philipp Dutkowski
15:55-16:10	My clinical practice of viability testing during NRP and ex-situ machine perfusion – Davide Ghinolfi
16:10-16:15	Q&A and Discussion

 

 

Session Room 5/ Track 5 Thursday, May 5, 15:30 – 16:30	Coagulation Workshop – ROTEM (supported by Werfen)
15:30-15:35	Welcome and Introduction – Valentina Pigozzo, Milan
15:35-16:15	ROTEM Algorithm Implementation and New Evidence – Klaus Görlinger, Munich
16:15-16:30	Live Discussion – Valentina Pigozzo, Milan and Klaus Görlinger, Munich

 

 

Session Room 5/ Track 5 Friday, May 6, 16:00 – 16:45	Liver Support and Ex Vivo Perfusion: from Organ Failure to Transplantation.
16:05-16:20	Extracorporeal therapies in liver failure – Ivano Riva, MD, Bergamo, Italy
16:21-16:36	The management of temperature in organ perfusion – Michele Colledan, MD, Bergamo, Italy
16:15-16:30	The role of purification in organ perfusion – Davide Ghinolfi MD, PhD, Pisa
16:52-17:00	Final Discussion with moderators and speakers